Northwest Biotherapeutics reported 477K in Sales Revenues for its second fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Sales Change
Agenus AGEN:US $ 20.93M 5.01M
Applied Genetic Technologies AGTC:US $ 0.32M 0.32M
AstraZeneca AZN:LN 884686.86M 17406.7M
Bristol Myers Squibb BMY:US $ 11887M 239M
Celldex Therapeutics CLDX:US $ 0.16M 0.01M
Cti Biopharma CTIC:US $ 12.33M 10.03M
Cytrx CYTR:US 0 0
Eisai 4523:JP Y 184262M 6639M
Genocea Biosciences GNCA:US $ 0.27M 0.27M
Infinity Pharmaceuticals INFI:US $ 0.69M 0.03M
Merk MRK:US $ 14593M 1308M
Mirati Therapeutics MRTX:US $ 5.36M 4.65M
Northwest Biotherapeutics NWBO:US 477K 74K
Pfizer PFE:US $ 27742M 2081M
Roche Holding ROG:VX 16.44B 474M